Cg. Begley, THE SCL TRANSCRIPTION FACTOR AND DIFFERENTIAL REGULATION OF MACROPHAGE DIFFERENTIATION BY LIF, OSM AND IL-6, Stem cells, 12, 1994, pp. 143-151
The SCL gene is a member of the helix-loop-helix family of transcripti
on factors. First identified because of its involvement in a rare chro
mosome translocation in human T cell acute lymphoblastic leukemia, it
is now recognized to be involved in up to 25% of T cell leukemias. Nor
mally within the hemopoietic system the gene is expressed in progenito
r cells, erythroid cells, mast cells and megakaryocytes. During macrop
hage differentiation the level of SCL mRNA and protein becomes undetec
table. To examine this further, SCL was over expressed in murine M1 ce
lls. This resulted in perturbation of macrophage differentiation induc
ed by leukemia inhibitory factor (LIF) and oncostatin-M (OSM) but not
interIeukin (IL)-6. Moreover the perturbation of LIF-induced d differe
ntiation applied to some components of macrophage differentiation but
not others. This suggests that signaling through the gp130 homodimer (
as occurs with IL-6) does not utilize an SCL-inhibitable pathway. In c
ontrast the LIF receptor/gp130 heterodimer does utilize an SCL-inhibit
able pathway for some elements of macrophage differentiation (e.g., ly
sozyme induction) but not others (e.g., M-CSF receptor induction).